Literature DB >> 29110944

Botulinum Toxin A for the Treatment of Photophobia and Dry Eye.

Ryan J Diel1, Zachary A Kroeger1, Roy C Levitt2, Constantine Sarantopoulos3, Heather Sered4, Jasmine Martinez-Barrizonte4, Anat Galor5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29110944      PMCID： PMC5741464          DOI： 10.1016/j.ophtha.2017.09.031

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   14.277


× No keyword cloud information.
  5 in total

Review 1.  Botulinum toxins: mechanisms of action, antinociception and clinical applications.

Authors:  Anthony Wheeler; Howard S Smith
Journal:  Toxicology       Date:  2013-02-19       Impact factor: 4.221

Review 2.  Diagnosis, pathophysiology, and treatment of photophobia.

Authors:  Bradley J Katz; Kathleen B Digre
Journal:  Surv Ophthalmol       Date:  2016-02-12       Impact factor: 6.048

3.  Advances in understanding the mechanisms of migraine-type photophobia.

Authors:  Rodrigo Noseda; Rami Burstein
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

Review 4.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 5.  Updates on the antinociceptive mechanism hypothesis of botulinum toxin A.

Authors:  K Roger Aoki; Joseph Francis
Journal:  Parkinsonism Relat Disord       Date:  2011-11       Impact factor: 4.891
  5 in total
  10 in total

Review 1.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 2.  Photophobia: When Light Hurts, a Review.

Authors:  Abdul Albilali; Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-30       Impact factor: 5.081

3.  Concurrent ocular pain in patients with neurotrophic keratopathy.

Authors:  Leyla Yavuz Saricay; Betul N Bayraktutar; Brendan M Kenyon; Pedram Hamrah
Journal:  Ocul Surf       Date:  2021-08-17       Impact factor: 6.268

4.  How Should Corneal Nerves be Incorporated Into the Diagnosis and Management of Dry Eye?

Authors:  Sneh Patel; Divy Mehra; Kimberly Cabrera; Anat Galor
Journal:  Curr Ophthalmol Rep       Date:  2021-05-20

5.  Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: Case series of four patients.

Authors:  Nandini Venkateswaran; Jodi Hwang; Andrew J Rong; Alexandra E Levitt; Ryan J Diel; Roy C Levitt; Konstantinos D Sarantopoulos; Wendy W Lee; Anat Galor
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-04

Review 6.  Alternative therapies for dry eye disease.

Authors:  Rhiya Mittal; Sneh Patel; Anat Galor
Journal:  Curr Opin Ophthalmol       Date:  2021-07-01       Impact factor: 4.299

7.  Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections.

Authors:  Ryan J Diel; Jodi Hwang; Zachary A Kroeger; Roy C Levitt; Constantine D Sarantopoulos; Heather Sered; Elizabeth R Felix; Jasmine Martinez-Barrizonte; Anat Galor
Journal:  Br J Ophthalmol       Date:  2018-09-29       Impact factor: 5.908

Review 8.  Photophobia in headache disorders: characteristics and potential mechanisms.

Authors:  Yajuan Wang; Shaoyang Wang; Tao Qiu; Zheman Xiao
Journal:  J Neurol       Date:  2022-03-23       Impact factor: 6.682

9.  Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.

Authors:  Marco Pellegrini; Costantino Schiavi; Leonardo Taroni; Stefano Sebastiani; Federico Bernabei; Matilde Roda; Fabiana Moscardelli; Giuseppe Giannaccare
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

10.  Differential Effects of Treatment Strategies in Individuals With Chronic Ocular Surface Pain With a Neuropathic Component.

Authors:  Sneh Patel; Rhiya Mittal; Elizabeth R Felix; Konstantinos D Sarantopoulos; Roy C Levitt; Anat Galor
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.